India Globalization Capital, Inc. (OTCMKTS: IGCC) Enters Hypergrowth CBD Space

India Globalization Capital, Inc. (OTCMKTS: IGCC) Enters Hypergrowth CBD Space


India Globalization Capital, Inc. (OTCMKTS: IGCC) is an infrastructure play that has ventured further and further into cannabis-infused beverages. IGCC has opted to move to the OTC as the switch in segments caused them to be halted on the NYSE as the company did not disclose their plans to venture into cannabis according to the exchange’s regulations.

However, one of the most interesting developments for IGCC centers around a patent from 2015 that treats pain with CBD applied topically. Details remain a littlle foggy but it appears to be 63% THC and 27% CBD with the remainder a mix of B-12 vitamins. Furthermore, on its website, IGCC said it had filed to obtain a patent for Hyalolex, a drug it said can address some symptoms of Alzheimer’s disease. The combination includes THC, tumeric, and melatonin, and it can help with the buildup of plaques and tangles, anxiety, aggression and sleep disorders in Alzheimer’s patients, the company said.

India Globalization Capital, Inc. (OTCMKTS: IGCC) was founded back in 2005 and its headquarters set for Bethesda, Maryland. The firm currently has two main portfolios: cannabis and legacy infrastructure, the former being the more recent development. The latter segment entails the firm trading infrastructure commodities such as iron and steel as well as renting heavy equipment necessary for the process. In cannabis, the firm has been engaged in the development and commercialization of cannabis-based solutions for Alzheimer patients, a number of endpoints of Parkinson’s, epilepsy, nausea as well as eating disorders. Moreover, there is also significant research going into the use of cannabis in the development of alternative therapies for chronic conditions as well as viruses such as AIDS.

Find out when $IGCC reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

Ram Mukunda, CEO of IGCC was quoted stating:

“By combining the experience of IGC with Hyalolex with the manufacturer in Malaysia, we potentially bring together unique expertise… This will help introduce an exciting CBD-infused energy drink to the market and the acquired knowledge base can be further leveraged to diversify the delivery method for IGC branded products…”

After IGCC was delisted from NYSE, it hit the OTC and the shares had taken a tumble due to normal fears. Yet, outside of that, there is probably strong growth value here as CBD beverages and CBD topicals are exploding into a huge market that is entirely separate of cannabis.

Earning a current market cap value of $32.16M, IGCC is going to go through some growing pains. The company is going to start with preliminary sales in Puerto Rico and this should be a bellwether on how well their new products are doing. As more color becomes clear on the name, we will review the situation and update our take. Sign-up for continuing coverage on shares of $IGCC stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $IGCC, either long or short, and we have not been compensated for this article.

Sign Up for our 100% FREE Oracle Dispatch Newsletter